Cargando…
FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer
Breast cancer is a major cause of cancer mortality worldwide. Fascin-1 (FSCN1) is an actin-binding protein found in mammalian cells, including endothelial, neuronal and mesenchymal cells. FSCN1 overexpression has been indicated in breast cancer patients. However, scant information is available regar...
Autores principales: | Wang, Chao-Qun, Tang, Chih-Hsin, Wang, Yan, Jin, Lulu, Wang, Qian, Li, Xiaoni, Hu, Gui-Nv, Huang, Bi-Fei, Zhao, Yong-Ming, Su, Chen-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698288/ https://www.ncbi.nlm.nih.gov/pubmed/29162880 http://dx.doi.org/10.1038/s41598-017-16196-6 |
Ejemplares similares
-
EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
por: Wang, Chao-Qun, et al.
Publicado: (2017) -
HMGB1 genetic polymorphisms are biomarkers for the development and progression of breast cancer
por: Huang, Bi-Fei, et al.
Publicado: (2018) -
Impacts of RETN genetic polymorphism on breast cancer development
por: Wang, Chao-Qun, et al.
Publicado: (2020) -
The impact of Angiopoietin-2 genetic polymorphisms on susceptibility for malignant breast neoplasms
por: Hu, Gui-Nv, et al.
Publicado: (2022) -
Correlation between CCL4 gene polymorphisms and clinical aspects of breast cancer
por: Hu, Gui-Nv, et al.
Publicado: (2018)